Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerule is a private U.S.-based wellness and nutraceutical company that markets science-positioned dietary supplements, skincare products, and related functional wellness products through a direct-selling and affiliate model. The company emphasizes patented ingredients and clinical-study support, with flagship products including StemEnhance ULTRA, PlasmaFlo, Cyactiv, and Cyactiv Joint. Its product positioning centers on stem cell support, circulation support, inflammation and mobility support, and skin rejuvenation rather than development of prescription therapeutics. Cerule describes itself as a biotech company, but operationally it appears closer to a commercial nutraceutical and wellness products business than a traditional drug-development biotech. The company sells internationally and is headquartered in Irvine, California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerule International.